Molecular models of multiple sclerosis severity identify heterogeneity of pathogenic mechanisms

Abstract

Multiple sclerosis (MS) changes the composition of the CSF. Here the authors use patient samples and aggregate CSF biomarkers into models that predict disability across all MS phenotypes, and identify potentially causal mechanisms and molecular disease heterogeneity.